Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine

Shaohang Cai(Key Laboratory of Guangdong Province), Jie Peng(Guiyang Medical University), Muye Xia(Southern Medical University), Tao Yu(Nanfang Hospital), Jiawei Cao(Ningbo No.6 Hospital)
Medicine
May 31, 2017
10.1097/md.0000000000007021
Cited by 34

Related Papers

Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging
|European Radiology|2019|219
Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling
|Cancer Research|2021|127
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China
|medRxiv|2020|112
<i>Retracted:</i><scp>HB</scp>x‐mediated decrease of <scp>AIM</scp>2 contributes to hepatocellular carcinoma metastasis
|Molecular Oncology|2017|92
Association Between Clinical Manifestations and Prognosis in Patients with COVID-19
|Clinical Therapeutics|2020|84